AMZNprintsminutestrendsdividendsdrawdownsP/E 28.4macronarrativesvolatilitybuybackssentiment+0.8%marginsMSFTPMI 52.1momentumdividendsflowsPMI 52.1digeststhreadsvolatilityearnings callsvolumesβ 1.24breakoutsnewsflow2s10sliquidityheadlines−1.2%breakoutsnoiseGOOGLbuybacksrevisionstrendsPMI 52.1briefstickersnoiseGDPsentimentchattertranscriptsGOOGLsentimentvolatilitybuybacksMSFTwhispersMETAsessionsyield curves13FfuturesdowngradesPMI 52.1headlinesthe tapeflowsdowngradesfutures+0.8%earnings callstranscriptsclosesgammacatalystsrevisionsvolatilitysentimentchatter+2.41%earnings callssentimentfilingstrends10y 4.21%cyclesbuybackswiresspx 0dtewhisperstickersQ3trendsnewsflowearnings callsWTI 78.2sentimentnoisethreadsrumorsnarrativesFOMCconsensusestimatesmomentumYoY +18%tickersmomentumprintsβ 1.24revisions

momentumheadlines52w hipositioning2s10sfilingstrendsprintstrendsmacrocyclesnoise2s10smacroQ3narrativesheadlinesflowscyclesnarrativesspreadstranscriptsdowngradesupgradeswhisperswhispersminutesthe tapeNDXfuturesminutesyield curves52w hithe tapeFOMCcatalystsbriefsthe tapeNVDAguidancetrends52w hidrawdowns2s10swhispersmomentumdrawdownsbuybacks

PCEliquiditysentimentbreakoutsdowngradesP/E 28.4threadsAAPLSPXvolatilityNDXflowscyclesliquidityestimatesEPS 4.12

ZYBT · NASDAQ · Drug Manufacturers - Specialty & Generic

Zhengye Biotechnology

Develops veterinary vaccines for livestock and dogs in China.

$1.71

After-hours close−0.01 (−0.58%)

At close$1.72(−2.27%)

Something off on this page? Send us feedback.

Profile

Zhengye Biotechnology Holding LimitedZYBTHealth Care

Develops, manufactures, and sells veterinary vaccines for livestock and dogs, serving China and selected export markets. The Nasdaq-listed Cayman parent controls its Jilin operating business through PRC subsidiaries.

Develops, manufactures, and sells veterinary vaccines for livestock and dogs. Its product line covers swine, cattle, goats, sheep, poultry, and dogs, while recent approvals expanded the portfolio across swine, poultry, cattle, and sheep.

Its products are available across provincial regions of China and exported to Vietnam, Pakistan, and Egypt. This keeps sales rooted in China while supplying selected overseas markets.

The listed security trades on Nasdaq through a Cayman holding company; shareholders hold the parent rather than direct equity interests in the PRC subsidiaries, which contain the Jilin operating business.

Company facts

CEOSonglin Song and Aiden Han

ListedJan 7, 2025

ExchangeNASDAQ

HeadquartersJilin, China

CountryChina

Employees269

CIK0001975641

ISINKYG989MS1016

Key statistics

Market cap$82.0M

EPS (ttm)−$0.2238

P/E (ttm)−7.73

ROE-26.8%

P/B2.21

P/S6.88

Dividend yield—

Beta−0.86vs XLV −4.17

Year to date +52.2% · Average volume (30d) 10.8M

Analysts

No analyst consensus on record.

Earnings

Not reported.

Financial highlights

	—	—	—	—	Q3 FY25	Q4 FY25
Revenue	—	—	—	—	$4.0M	$7.9M
Gross profit	—	—	—	—	$333.7K	$655.0K
Operating income	—	—	—	—	−$3.1M	−$6.1M
Net income	—	—	—	—	−$3.6M	−$7.0M
Diluted EPS	—	—	—	—	−$0.08	−$0.15
Gross margin	—	—	—	—	8.3%	8.3%
Operating margin	—	—	—	—	-77.0%	-77.0%

Balance sheet, Dec 31, 2025Cash & short-term investments $7.7M · Total debt $11.2M · Total assets $64.9M · Shareholders' equity $37.2M

Dividends

No dividends on record.

Ownership

Institutions 0.26%121.0K sharesInsiders 84.40%40.00M sharesOther 15.34%7.27M shares

Shares outstanding 47.39M · Float 4.43M · 9.3% free float

Top shareholders13F · 13D/G · Form 4

Holder	Shares	% outstanding	Form	Filed
Securingium Holding Limited	42.96M	90.66%	13G	Feb 21, 2025
Zhenfa Han · director, 10 percent owner:	40.00M	84.40%	Form 4	Jun 25, 2026
XTX Topco Ltd	44.1K	0.09%	13F	May 15, 2026
Winton Group Ltd	33.4K	0.07%	13F	May 12, 2026
Geode Capital Management, LLC	29.1K	0.06%	13F	May 15, 2026

Insider tradesForm 4

Nothing filed in the last 12 months.

View details

Peers